Immune targets for chemotherapy-resistant breast cancers identified 26 Sep 2022 Researchers perform a deep dive into the different immune markers within tumour tissue and blood samples of early breast cancer patients whose cancer failed to respond to chemotherapy given to them prior to surgery - the findings could help tailor pre-surgical treatment. Find out more Show/Hide
Long-term benefit of combining chemotherapy and radiotherapy in bladder cancer 02 Aug 2022 Giving people with bladder cancer chemotherapy and radiotherapy at the same time helps stop cancer from coming back, long-term results of a 10-year study confirm. Find out more Show/Hide
Aggressive childhood cancer could be treated by combining DNA-damage targeting drugs 29 Sep 2020 An aggressive form of the childhood cancer neuroblastoma could be treatable with two cancer drugs currently used in the treatment of colon and ovarian cancer, a study led by researchers at The Institute of Cancer Research, London, suggests. Find out more Show/Hide
ASCO 2019: Immunotherapy better than aggressive chemotherapy as first treatment option for recurrent head and neck cancer 04 Jun 2019
ESMO 2018: Immunotherapy effective as first-line treatment for advanced head and neck cancer 22 Oct 2018